Brief: Tandem Study- Adults With Type 2 Diabetes Benefit From Automated Insulin Delivery, Regardless of C-Peptide Levels
Sept 16 (Reuters) - Tandem Diabetes Care Inc TNDM.O: TANDEM DIABETES CARE ANNOUNCES PUBLICATION SHOWING ADULTS WITH TYPE 2 DIABETES BENEFIT FROM AUTOMATED INSULIN DELIVERY REGARDLESS OF C-PEPTIDE LEVELS Source text: ID:nBw81Hk4Ga Further company coverage: TNDM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tandem Diabetes Care
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30 - Earnings Summary